We are live on ! Find out more
BEAM icon

Beam Therapeutics
BEAM

224 hedge funds and large institutions have $2.6B invested in Beam Therapeutics in 2022 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 74 increasing their positions, 65 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

247% more call options, than puts

Call options by funds: $53.9M | Put options by funds: $15.5M

76% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 25

24% more capital invested

Capital invested by funds: $2.09B → $2.6B (+$509M)

14% more repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 65

9% more funds holding

Funds holding: 205 → 224 (+19)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

0.26% less ownership

Funds ownership: 77.81% → 77.55% (-0.26%)

Holders
224
Holders Change
+19
Holders Change %
+9.27%
% of All Funds
3.86%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
44
Increased
74
Reduced
65
Closed
25
Calls
$53.9M
Puts
$15.5M
Net Calls
+$38.4M
Net Calls Change
+$44.4M

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$52.9M
2
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
+$21.4M
3
EAM
Eventide Asset Management
Massachusetts
+$15.2M
4
HRCM
Hood River Capital Management
Florida
+$13.1M
5
NAMA
Nikko Asset Management Americas
New York
+$12.5M

Top Sellers

1
Temasek Holdings
Temasek Holdings
Singapore
-$62.3M
2
State Street
State Street
Massachusetts
-$44.1M
3
AIM
ARK Investment Management
Florida
-$17.2M
4
DTC
Deep Track Capital
Connecticut
-$14.3M
5
Millennium Management
Millennium Management
New York
-$13.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
AI
26
Alphabet Inc
California
$15.3M – – –
EAM
27
Eventide Asset Management
Massachusetts
$12.7M +$15.2M +267,025 New
Mirae Asset Global Investments
28
Mirae Asset Global Investments
South Korea
$11.7M +$1.9M +33,357 +16%
N
29
Nuveen
North Carolina
$11.6M +$770K +13,491 +6%
HRCM
30
Hood River Capital Management
Florida
$11M +$13.1M +229,979 New
Voloridge Investment Management
31
Voloridge Investment Management
Florida
$10.2M -$6.4M -112,274 -34%
Schroder Investment Management Group
32
Schroder Investment Management Group
United Kingdom
$10M -$3.87M -67,862 -24%
Two Sigma Investments
33
Two Sigma Investments
New York
$9.48M +$9.23M +161,878 +436%
Millennium Management
34
Millennium Management
New York
$8.01M -$13.2M -232,258 -58%
Citigroup
35
Citigroup
New York
$6.44M -$1.09M -19,104 -12%
Swiss National Bank
36
Swiss National Bank
Switzerland
$6.35M +$274K +4,800 +4%
California Public Employees Retirement System
37
California Public Employees Retirement System
California
$6.19M +$2.36M +41,331 +47%
Rafferty Asset Management
38
Rafferty Asset Management
New York
$5.9M +$168K +2,952 +2%
Bank of America
39
Bank of America
North Carolina
$5.71M -$1.05M -18,485 -13%
GGHC
40
Gilder Gagnon Howe & Co
New York
$5.68M -$716K -12,556 -10%
Lazard Asset Management
41
Lazard Asset Management
New York
$5.42M +$332K +5,820 +5%
RSCM
42
Rock Springs Capital Management
Maryland
$5.31M – – –
GIM
43
Granahan Investment Management
Massachusetts
$5.26M +$1.68M +29,507 +36%
Barclays
44
Barclays
United Kingdom
$5.18M +$4.46M +78,267 +257%
CAI
45
Capital Advisors Inc
Oklahoma
$5M +$62.6K +1,098 +1%
Two Sigma Advisers
46
Two Sigma Advisers
New York
$4.81M +$2.89M +50,600 +100%
Citadel Advisors
47
Citadel Advisors
Florida
$4.49M +$2.34M +41,000 +77%
Arrowstreet Capital
48
Arrowstreet Capital
Massachusetts
$4.46M +$2.21M +38,699 +70%
N
49
Natixis
France
$4.41M +$1.94M +33,959 +58%
VOYA Investment Management
50
VOYA Investment Management
Georgia
$4.4M +$1.02M +17,903 +24%
1
2
3 4 5

BEAM Hedge Fund Activity: Q3 2022 in Review

224 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Beam Therapeutics (BEAM) for Q3 2022, worth a combined $2.6B — up 24% from $2.09B a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new BEAM positions and 25 closed out — a net gain of 19 holders — while 74 added to existing stakes and 65 trimmed.

The largest buyer was Vanguard Group, adding an estimated $52.9M. The largest seller was Temasek Holdings, cutting an estimated $62.3M.

  • 224 institutional investors held Beam Therapeutics (BEAM) as of Q3 2022, up from 205 in Q2 2022.
  • Funds reported $2.6B of Beam Therapeutics stock for Q3 2022, up 24% quarter-over-quarter.
  • 44 funds opened new Beam Therapeutics positions in Q3 2022 and 25 closed out, a net change of +19 holders.
  • The largest Beam Therapeutics buyer in Q3 2022 was Vanguard Group, an estimated $52.9M added.
  • The largest Beam Therapeutics seller in Q3 2022 was Temasek Holdings, an estimated $62.3M sold.

Based on aggregated 13F filings for Q3 2022.